Re: smartinsulin any news?
[ Follow-Ups ]
[ Post Followup ]
[ The Islet Foundation Public Message Forum ]
Posted by zori on 15:39:44 2010/02/20
In Reply to:
smartinsulin any news? posted by katerina
No, but they have received a lot of funding in 2009. Last I heard they were going to start human trials in 2011
September 25, 2009 SmartCells, Inc. Awarded Phase II SBIR by NIH/NIDDK
SmartCells, Inc. received notice that it has been awarded $1,578,278 in first year funding for a Phase II SBIR grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). The grant was awarded to support IND-enabling toxicology and safety pharmacology studies of SmartInsulin, the company's glucose-regulated insulin formulation. The second year of the Phase II grant allocates $337,365 in additional funding.
August 1, 2009 SmartCells, Inc. Receives Additional Phase II SBIR Funds from NIH/NIDDK
SmartCells, Inc. received notice that it has been awarded $850,859 in second year funding for a Phase II SBIR grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH). The funds will support manufacturing development for the company's glucose-regulated insulin formulation. Support for the second year was provided on the basis of achieving goals during the first year of the grant, which provided $1,546,698 in funding.
July 28, 2009 - SmartCells Completes Convertible Debt Financing
SmartCells, Inc. completed the sale of $1.15 million in Convertible Notes on July 28, 2009, all to current shareholders. The size of the offering was increased to accommodate purchase requests. Purchasers include members of the Boston Harbor Angels, Angel Healthcare Investors, Beacon Street Angels, Cherrystone Angels and Common Angels. Dr. Todd C. Zion, SmartCells' co-founder, President and CEO said, "I am gratified at the continuing support from our Series A, B and C investors who belong to the Boston area's leading angel investing groups. The proceeds, together with grant awards, will help support the safety testing and manufacturing work needed to move SmartInsulin, our glucose-responsive insulin formulation, into the clinic".
Follow Ups:
Post a Followup
[ Follow Ups ]
[ Post Followup ]
[ The Islet Foundation Public Message Forum ]